Jingrong Jean Cui
CIK: 0001772259
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BlossomHill Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
Conversion(C)Indirect1.6M shares- - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
Conversion(C)Indirect113.4K shares- - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
Conversion(C)Indirect124.8K shares- - Aug 6, 2026BLSM
BlossomHill Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
676.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion(C) | 1,600,682 | - | $0 | Indirect |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion(C) | 113,435 | - | $0 | Indirect |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion(C) | 124,779 | - | $0 | Indirect |
| Aug 6, 2026 | BLSM BlossomHill Therapeutics, Inc. | Award(A) Employee Stock Option (Right to Buy) | 676,205 | - | - | Direct |
1-4 of 4 transactions
About Cui Jingrong Jean
Cui Jingrong Jean (SEC CIK 0001772259) files insider reports with the SEC as President and CEO of BlossomHill Therapeutics, Inc. (BLSM).
Signal8 holds 2 ownership filings by Cui Jingrong Jean (1 Form 3, 1 Form 4), filed between Aug 6, 2026 and Aug 10, 2026. Those filings report 4 transactions, from Aug 6, 2026 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cui Jingrong Jean's filings is in SAN DIEGO, CA.
Recent filings by Cui Jingrong Jean
Other insiders filing for BlossomHill Therapeutics, Inc. (BLSM)
- GORDON CARL L, Director
- ORBIMED ADVISORS LLC, Director
- Schmid John P., Director
- Chen Bihua, Director
- Agrawal Sundeep, Director
- Keyes Jason A, Chief Financial Officer